Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Dyadic International Inc. (DYAI) vs Pasithea Therapeutics Corp. (KTTA)

Dyadic International Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Dyadic International Inc. and Pasithea Therapeutics Corp. are of similar size ($17.4M and $17.2M). Pasithea Therapeutics Corp. has the higher net margin (0.00% vs −200.5%) and the lower return on invested capital (−367.5% vs 0.00%). Across the 15 metrics below, Dyadic International Inc. leads on 8 and Pasithea Therapeutics Corp. on 7.

Valuation

Metric DYAI KTTA Biotechnology median
P/E n/m n/m 7.88
P/S 4.03 32.98 11.47
P/B n/m 0.32 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.28 0.74
EV/Sales 4.12 (61.07) 10.73
Earnings yield (54.76%) (316.00%) (28.84%)
Free cash flow yield (49.10%) (109.92%) (23.03%)

Profitability

Metric DYAI KTTA Biotechnology median
Gross margin 16.24% 0.00% 65.16%
Operating margin (195.47%) 0.00% 0.00%
Net margin (200.46%) 0.00% 0.00%
Free cash flow margin (194.73%) 0.00% 0.00%
Return on equity 522.58% (65.49%) (57.72%)
Return on assets (103.88%) (61.97%) (49.22%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric DYAI KTTA Biotechnology median
Revenue growth (TTM) (8.05%) — 5.64%
EPS growth (last fiscal year) (15.00%) 77.07% —
Revenue growth, 5-year CAGR 14.04% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYAI KTTA Biotechnology median
Debt to equity (2.11) 0.00 0.00
Current ratio 1.65 26.25 4.73
Net debt to EBITDA 0.49 2.74 0.96

Dividend

Metric DYAI KTTA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DYAI KTTA Biotechnology median
Market cap 17.44m 17.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack